The invention is directed to compounds of Formula (I):
to pharmaceutical compositions containing such compounds and to methods of treatment using them.
该发明涉及公式(I)的化合物,涉及含有这些化合物的制药组合物以及使用它们的治疗方法。
US7951829B2
申请人:——
公开号:US7951829B2
公开(公告)日:2011-05-31
Benzimidazole Modulators of VR1
申请人:Player Mark R.
公开号:US20070259936A1
公开(公告)日:2007-11-08
The invention is directed to compounds of Formula (I):
to pharmaceutical compositions containing such compounds and to methods of treatment using them.